IPH4102 (lacutamab)

lacutamab · Innate Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPH4102 (lacutamab), covering 2024-11-08 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma [Phase 2]